Aliquots - Research Briefs

July 18, 2016

Diabetes drugs may ease addiction

Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse.

By Bill Snyder

July 15, 2016

Work together to control diabetes

Parenting behaviors may be an important target for improving outcomes in adolescents with diabetes.

By Leigh MacMillan

water drops splashing against solid surface

July 14, 2016

Membrane fats impact drug transporter

New studies of a membrane transporter could explain antibiotic resistance – and lead to novel ways to combat it.

By Bill Snyder

June 29, 2016

M.D. affiliation and Medicaid access

By Paul Govern

June 27, 2016

The odds of asthma

A number of factors during infancy increase the risk that a child will later develop asthma.

By Paul Govern

June 24, 2016

Superior scan for tumors

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors.

By Bill Snyder

June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.

By Bill Snyder

June 6, 2016

Pulmonary fibrosis culprits

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.

By Leigh MacMillan

June 3, 2016

Pregnancy-related heart disorder clues

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.

By Yan Su

June 2, 2016

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

By Leigh MacMillan

May 13, 2016

New pain medicine from a fungus?

Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines.

By Sanjay Mishra

May 12, 2016

COX-2 blocker could help PTSD

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression.

By Bill Snyder

May 3, 2016

Drug combos for glioblastoma

Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.